Targeting the HIV-1 Spike and Coreceptor with Bi- and Trispecific Antibodies for Single-Component Broad Inhibition of Entry

Protection against acquiring human immunodeficiency virus (HIV) infection may not require a vaccine in the conventional sense, because broadly neutralizing antibodies (bNAbs) alone prevent HIV infection in relevant animal challenge models. Additionally, bNAbs as therapeutics can effectively suppress...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Virol
Autores principales: Khan, Salar N., Sok, Devin, Tran, Karen, Movsesyan, Arlette, Dubrovskaya, Viktoriya, Burton, Dennis R., Wyatt, Richard T.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2018
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6146690/
https://ncbi.nlm.nih.gov/pubmed/29976677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.00384-18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares